Has Jonathan Yang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $177,892 in general payments to Jonathan Yang, MD across 666 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan Yang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan Yang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan Yang, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Austin, TXNPI 1528206901

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $137,886 of the $177,892 with a category attached, or 77.5%. Atricure, Inc. accounts for 61.1% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2022 at $84,985 and has fallen 77.3% since, to $19,265 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$177,892in general payments, 2019–2025

Across 666 payments — averaging $267.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Atricure, Inc.$109K
Abbott$56K
Abiomed$7K
Medtronic$3K
Intuitive Surgical$626
Zimmer Biomet$377
plus $3K from 16 others

$25,174in research payments, 2019–2025

Across 12 payments — averaging $2097.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$25K

What the payments were for

Consulting fees$137,88678%
Travel & lodging$15,3449%
Food & beverage$24,66214%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Atricure, Inc.	136	$108,669
Abbott	321	$55,865
Abiomed	133	$6,860
Medtronic(2 entities)	36	$2,984
Intuitive Surgical	4	$626
Zimmer Biomet	5	$377
Penumbra, Inc.	4	$360
Elutia, Inc.	2	$328
Edwards Lifesciences	7	$282
Stryker	3	$232
Smith+Nephew	2	$173
Core Surgical Group	1	$168
Bolton Medical Inc	1	$150
BD	2	$144
Livanova USA, Inc.	1	$134
Kiniksa Pharmaceuticals International, PLC	1	$129
Getinge USA Sales, LLC	1	$126
Shockwave Medical, Inc	1	$119
Silk Road Medical, Inc.	1	$49
LSI Solutions Inc	1	$40
W. L. Gore & Associates, Inc.	1	$38
Boston Scientific	2	$36

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$100,389
ATRICLIP LAA EXCLUSION SYSTEM$55,543
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$15,302
HeartMate 3 Left Ventricular Dev$13,349
HeartMate 3 Left Ventricular Assist Device$13,251
DISSECTOR$5,000
CardioMEMS HF System$4,455
ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$2,235
Impella$2,134
SYNERGY ABLATION SYSTEM$2,019
2ND GEN CENTRIMAG PRIMARY CONSOLE$1,684
CentriMag$1,260
CARDIOMEMS$911
HeartWare HVAD$728
Arctic Front$684
Da Vinci Surgical System$588
ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$529
ECM Patch,Pouch$328
Epic$295
STERNALOCK 360 SYSTEM$275

How this compares

$177,892 in reported general payments places this provider in the 95th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas →

Medicare billing

Part B allowed, 2024

$85,501

Medicare patients

Services billed

199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Losartan Potassium	13	$42
Furosemide	12	$34

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Austin

Faraz KerendiAustin$906K
Brannon HydeAustin$214K
Masahiro OnoAustin$119K
Eric HoenickeAustin$61K
Jeffrey McNeilAustin$49K
Brendan DewanAustin$46K
Robert HebelerDallas$723K
Michael ReardonHouston$713K
Danny RamzyHouston$527K
Scott OlssonCypress$357K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →